Anti-Cd19 Antibody Drug Conjugates
Copyright © Targeted News Service 2024
2024-10-22
ALEXANDRIA, Virginia, Oct. 22 -- ABBVIE BIOTHERAPEUTICS INC., North Chicago, Illinois has been assigned a patent (No. US 12121589 B2, initially filed June 15, 2023) developed by three inventors Adrian D. Hobson, Shrewsbury, Massachusetts; Christopher C. Marvin, Grayslake, Illinois; and James W. Purcell, San Francisco, California, for "Anti-CD19 antibody drug conjugates." . . .